Evidence map›Paper›PMID 40256524›Full record

ArticleACS omega2025

Biodegradable Microneedle Patch Confers Crocin with Outstanding Effects in the Treatment of Myocardial Infarction.

Qian Liu, Rui Zhao, Danni Zhang, Zhaohuan Lou, Jiangyue Wu, Shiying Hou, Bin Yang, Yunyun Lu, Mengyao Yuan, Shudong Lin and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qian LiuSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID https://orcid.org/0000-0003-1437-3759
Rui ZhaoSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Danni ZhangSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhaohuan LouSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Jiangyue WuSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Shiying HouSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Bin YangSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yunyun LuSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Mengyao YuanSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Shudong LinSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Tianlei WangSchool of Engineering and Applied Science, University of Pennsylvania, Philadelphia 19104-6243, Pennsylvania, United States.ORCID https://orcid.org/0009-0001-5633-5710
Liang JinSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Ling ZhangSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.ORCID https://orcid.org/0000-0001-7542-1879

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crocin (CRO), the main active component of

Identifiers

PMID40256524
PMCPMC12004187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.